Immunomodulatory therapy in advanced multiple sclerosis

from JNNP podcast · host BMJ Group

Could currently available immunomodulatory therapies modify disability trajectories in patients with moderately advanced and advanced multiple sclerosis (MS)? Tomas Kalincik, Department of Medicine, University of Melbourne, Australia, discusses the findings from the MSbase cohort study with Elizabeth Highton. Read the full article here: http://jnnp.bmj.com/content/88/3/196.

Episode metadata supplied by the publisher feed · Published Mar 10, 2017

Embed this episode

Attribution link and audio player

Ready to play

Immunomodulatory therapy in advanced multiple sclerosis

0:00 14:04

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JNNP podcast?

This episode is 14 minutes long.

When was this JNNP podcast episode published?

This episode was published on March 10, 2017.

Can I download this JNNP podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!